NO180588C - Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser med platina - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser med platina

Info

Publication number
NO180588C
NO180588C NO912732A NO912732A NO180588C NO 180588 C NO180588 C NO 180588C NO 912732 A NO912732 A NO 912732A NO 912732 A NO912732 A NO 912732A NO 180588 C NO180588 C NO 180588C
Authority
NO
Norway
Prior art keywords
platinum
preparation
active compounds
therapeutically active
analogous process
Prior art date
Application number
NO912732A
Other languages
English (en)
Norwegian (no)
Other versions
NO912732D0 (no
NO180588B (no
NO912732L (no
Inventor
Abdolhossen Talebian
Dianna C Green
Philip S Schein
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of NO912732D0 publication Critical patent/NO912732D0/no
Publication of NO912732L publication Critical patent/NO912732L/no
Publication of NO180588B publication Critical patent/NO180588B/no
Publication of NO180588C publication Critical patent/NO180588C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO912732A 1989-01-17 1991-07-11 Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser med platina NO180588C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29736889A 1989-01-17 1989-01-17
US07/301,773 US4946954A (en) 1989-01-17 1989-01-26 Platinum pharmaceutical agents
PCT/US1990/000171 WO1990008157A1 (en) 1989-01-17 1990-01-17 Platinum pharmaceutical agents

Publications (4)

Publication Number Publication Date
NO912732D0 NO912732D0 (no) 1991-07-11
NO912732L NO912732L (no) 1991-07-11
NO180588B NO180588B (no) 1997-02-03
NO180588C true NO180588C (no) 1997-05-14

Family

ID=26970120

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912732A NO180588C (no) 1989-01-17 1991-07-11 Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser med platina

Country Status (13)

Country Link
US (1) US4946954A (de)
EP (1) EP0462980A4 (de)
JP (1) JP2771326B2 (de)
AU (2) AU5039490A (de)
CA (1) CA2045120A1 (de)
HU (1) HUT59690A (de)
IL (1) IL93090A (de)
NO (1) NO180588C (de)
NZ (1) NZ232134A (de)
PH (1) PH26424A (de)
RU (1) RU2074861C1 (de)
WO (1) WO1990008157A1 (de)
ZA (1) ZA90336B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
WO1990012018A1 (en) * 1989-04-04 1990-10-18 Daikin Industries, Ltd. New fluorocarbon platinum complexes
US5871710A (en) * 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
AU2701395A (en) * 1994-06-27 1996-01-19 General Hospital Corporation, The Graft co-polymer adducts of platinum (ii) compounds
ATE246696T1 (de) * 1995-05-09 2003-08-15 Kreatech Biotech Bv Verfahren zur herstellung von linkern zwischen markierungsgruppen und bio-organischen molekülen auf der basis von platin für die markierung von bio-organischen molekülen zur entdeckung interessanter biologischer substanzen
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
US6235776B1 (en) 1998-11-12 2001-05-22 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
US6235782B1 (en) 1998-11-12 2001-05-22 Rifat Pamukcu Method for treating a patient with neoplasia by treatment with a platinum coordination complex
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU2006222657B2 (en) * 2000-01-04 2009-01-15 Access Pharmaceuticals, Inc. N,O-amidomalonate platinum complexes
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
KR100729015B1 (ko) * 2000-01-04 2007-06-14 어섹스 팔마큐티칼스 인코포레이티드 N,o-아미도말로네이트 백금 착화합물
KR20040074857A (ko) * 2003-02-19 2004-08-26 학교법인 이화학당 N-치환 아미노디카복실산의 백금(ⅱ) 착물 및 그 제조방법
KR100499340B1 (ko) * 2003-04-29 2005-07-04 학교법인 이화학당 암 조직 선택성과 생분해성을 갖는폴리포스파젠-백금(ⅱ)착물 복합체 항암제 및 그 제조방법
WO2006091790A1 (en) * 2005-02-23 2006-08-31 Xenoport, Inc. Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use
RU2319491C1 (ru) 2006-07-12 2008-03-20 Бадулин Николай Александрович Противоопухолевая, антибактериальная и антивирусная фармацевтическая композиция (ее варианты)
US8389506B2 (en) * 2007-12-07 2013-03-05 Prana Biotechnology Ltd. Compounds for therapy and diagnosis
ES2704303T3 (es) 2010-08-24 2019-03-15 Dana Farber Cancer Inst Inc Procedimientos para la predicción de una respuesta contra el cáncer
EP3693473A1 (de) 2011-06-17 2020-08-12 Myriad Genetics, Inc. Methoden und materialien zur beurteilung des allelischen ungleichgewichts
CN102863474A (zh) 2011-07-09 2013-01-09 陈小平 一类治疗细胞增殖性疾病的铂化合物、其制备方法和应用
CN102993239A (zh) * 2011-09-19 2013-03-27 陈小平 离去基团含氨基或烷胺基的丁二酸衍生物的铂类化合物
CN103703011B (zh) * 2011-12-07 2016-06-22 北京市丰硕维康技术开发有限责任公司 一类离去基团是含氨基或烷氨基的羟基酸衍生物的铂类化合物及其制备方法和应用
AU2012358244A1 (en) 2011-12-21 2014-06-12 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
CA3080441A1 (en) 2012-02-23 2013-09-06 The Children's Hospital Corporation Methods for predicting anti-cancer response
NZ630278A (en) 2012-06-07 2017-02-24 Inst Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
WO2014160080A1 (en) 2013-03-14 2014-10-02 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
EP3007709B1 (de) 2013-06-14 2021-12-08 Akamara Therapeutics, Inc. Lipidbasierte platinverbindungen und nanopartikel
WO2014203691A1 (ja) * 2013-06-18 2014-12-24 株式会社ヤクルト本社 白金錯体を含有する新規医薬
WO2015086473A1 (en) 2013-12-09 2015-06-18 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
EP3686288B1 (de) 2014-08-15 2023-03-08 Myriad Genetics, Inc. Verfahren und materialien zur beurteilung eines mangels an homologer rekombination
CN107847457B (zh) 2015-05-19 2022-07-05 阿卡马拉医疗公司 制备超分子铂基化合物的方法
US20210137874A1 (en) * 2017-03-22 2021-05-13 The Regents Of The University Of California Modified platinum compounds and therapeutic uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
US4284579A (en) * 1979-07-17 1981-08-18 The United States Of America As Represented By The Of The Department Of Health & Human Services (N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
JPS5921697A (ja) * 1982-06-24 1984-02-03 Yoshinori Kitani 新規な白金錯体
US4673754A (en) * 1983-10-14 1987-06-16 Inco Alloys International, Inc. Platinum and palladium complexes
IL73337A (en) * 1984-10-28 1988-09-30 Yissum Res Dev Co Antitumor steroid-platinum complexes and method for the preparation thereof
US4587331A (en) * 1984-12-17 1986-05-06 American Cyanamid Company Platinum complexes of polyhydroxylated alkylamines and 2-polyhydroxylated alkyl-1,2-diaminoethanes
US4882447A (en) * 1987-02-20 1989-11-21 Tanabe Seiyaku Co., Ltd. Novel organic platinum complex and process for the preparation thereof
ATE87314T1 (de) * 1987-07-17 1993-04-15 Univ Georgetown Platin-arzneimittel.

Also Published As

Publication number Publication date
AU674185B2 (en) 1996-12-12
AU5479294A (en) 1994-03-31
NZ232134A (en) 1992-09-25
HUT59690A (en) 1992-06-29
US4946954A (en) 1990-08-07
IL93090A0 (en) 1990-11-05
NO912732D0 (no) 1991-07-11
CA2045120A1 (en) 1990-07-18
WO1990008157A1 (en) 1990-07-26
JPH04502767A (ja) 1992-05-21
JP2771326B2 (ja) 1998-07-02
PH26424A (en) 1992-07-15
RU2074861C1 (ru) 1997-03-10
NO180588B (no) 1997-02-03
EP0462980A1 (de) 1992-01-02
IL93090A (en) 1995-10-31
AU5039490A (en) 1990-08-13
ZA90336B (en) 1990-10-31
EP0462980A4 (en) 1992-03-11
NO912732L (no) 1991-07-11

Similar Documents

Publication Publication Date Title
NO180588C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser med platina
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
FI881223A0 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO175478C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
NO175100C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO178069C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive platinakomplekser
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater